ArticleUrologic oncology2020

Nivolumab plus ipilimumab as neoadjuvant treatment in primary advanced renal cell tumors: Cutting edges for cutting-edge surgery.

Karlijn de Joode et al.PubMed ↗Publisher ↗

No numbers read from the abstract.